Biogen Slips To Loss In Q3; Raises Low-end Of FY26 Earnings View
(RTTNews) - Biotech major Biogen Inc. (BIIB) reported Wednesday a loss in its third quarter, compared to prior year's profit, despite higher revenues. Further, the firm raised the lower end of fiscal 2026 earnings outlook, on a reported basis, and tightened underlying earnings vi
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.